MIM
AKTS

MetLife Investment Management’s Akoustis Technologies Inc AKTS Stock Holding History

MetLife Investment Management’s Portfolio AKTS Stock Details AKTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-39,725
Closed -$126K – 2996
2023
Q2 		$126K Buy
39,725
+7,313
+23% +$22.4K ﹤0.01% 2542
2023
Q1 		$99.8K Buy
32,412
+16,255
+101% +$56.7K ﹤0.01% 2556
2022
Q4 		$45.6K Sell
16,157
-11,516
-42% -$36.2K ﹤0.01% 2769
2022
Q3 		$82.2K Hold
27,673
– – ﹤0.01% 2719
2022
Q2 		$102K Buy
27,673
+19,902
+256% +$88.2K ﹤0.01% 2706
2022
Q1 		$50.5K Sell
7,771
-9,490
-55% -$56.5K ﹤0.01% 2678
2021
Q4 		$115K Buy
17,261
+9,470
+122% +$70.7K ﹤0.01% 2359
2021
Q3 		$75.6K Sell
7,791
-8,187
-51% -$78.5K ﹤0.01% 2507
2021
Q2 		$171K Buy
15,978
+11,598
+265% +$123K ﹤0.01% 2249
2021
Q1 		$58.4K Sell
4,380
-9,843
-69% -$143K ﹤0.01% 2278
2020
Q4 		$174K Buy
14,223
+459
+3% +$4.02K ﹤0.01% 2052
2020
Q3 		$112K Hold
13,764
– – ﹤0.01% 2166
2020
Q2 		$114K Buy
+13,764
New +$106K ﹤0.01% 2193

Other funds holding AKTS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SAM
Silverback Asset Management Chapel Hill, North Carolina $699M AUM 72.42% 1-Year Est. Return
Capstone Investment Advisors
Capstone Investment Advisors New York $57.4B AUM 26.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return
HIM
Herald Investment Management London, United Kingdom $737M AUM 158.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

MetLife Investment Management's AKTS Position: Q3 2023 in Review

MetLife Investment Management sold out of Akoustis Technologies Inc (AKTS) in Q3 2023, closing a stake of 39,725 shares — an estimated $126K sold.

MetLife Investment Management first reported a position in AKTS in Q2 2020 and held it in 13 quarters. The position peaked at $174K in Q4 2020. 120 funds tracked by Wall St. Rank hold AKTS as of Q3 2023.

  • MetLife Investment Management reported no remaining Akoustis Technologies Inc position as of Q3 2023 after selling out during the quarter.
  • MetLife Investment Management sold 39,725 Akoustis Technologies Inc shares in Q3 2023, an estimated $126K.
  • MetLife Investment Management first reported a position in Akoustis Technologies Inc in Q2 2020 and held it in 13 quarters.
  • MetLife Investment Management's Akoustis Technologies Inc position peaked at $174K in Q4 2020.
  • 120 funds tracked by Wall St. Rank held Akoustis Technologies Inc as of Q3 2023.

Based on MetLife Investment Management's 13F filing for Q3 2023, filed 14 Nov 2023.